Naresh Tondare
Head – India and Nepal Regulatory Affairs
Glenmark Pharmaceuticals
B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.
http://www.glenmarkpharma.com/
12 years’ experience in Regulatory Affairs (India, India and Bhutan) and Global Clinical Regulatory Affairs (EU, ROWand India). Responsible for generic, branded generic and NCE products.
Responsible and accountable for Global CMC Regulatory Affairs (India, Nepal, Bhutan, Bangladesh and ROW markets), Global Clinical Regulatory Affairs (EU, US, ROW and India) and Regulatory Intelligence/strategy. Products include Complex Generics, Frist Generics, Generics, Novel Fixed Dose combinations (FDCs) New Drugs (India), Consumer Healthcare, OTC and New Chemical Entity (NCEs).
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…